{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:13:25Z","timestamp":1789017205716,"version":"build-2803163510"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T00:00:00Z","timestamp":1585612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00524","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T08:17:09Z","timestamp":1585642629000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":165,"title":["Diagnosis and Management of Secondary HLH\/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP)"],"prefix":"10.3389","volume":"11","author":[{"given":"Robert David","family":"Sandler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel Scarlett","family":"Tattersall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Schoemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Badoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Labopin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirill","family":"Kirgizov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Rovira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Saif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Saccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinaida","family":"Peric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Koenecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Penack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Basak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Andrew","family":"Snowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/rheumatology\/key006","article-title":"Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment","volume":"58","author":"Carter","year":"2019","journal-title":"Rheumatology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s12185-009-0261-1","article-title":"Hemophagocytic syndrome after hematopoietic stem cell transplantation: a prospective observational study","volume":"89","author":"Abdelkefi","year":"2009","journal-title":"Int J Hematol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1136\/adc.85.5.421","article-title":"Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders","volume":"85","author":"Sawhney","year":"2001","journal-title":"Arch Dis Child."},{"key":"B4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/pbc.23384","article-title":"Hemophagocytic lymphohistiocytosis after hematopoietic stem cell transplantation in children: a nationwide survey in Japan","volume":"59","author":"Asano","year":"2012","journal-title":"Pediatr Blood Cancer."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1080\/10428194.2016.1262034","article-title":"Diagnostic value of serum ferritin and the risk factors and cytokine profiles of hemophagocytic syndrome following allogeneic hematopoietic cell transplantation","volume":"58","author":"Nanno","year":"2017","journal-title":"Leuk Lymphoma."},{"key":"B6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41409-019-0637-7","article-title":"Haemophagocytic lymphohistiocytosis (HLH) following allogeneic haematopoietic stem cell transplantation (HSCT)-time to reappraise with modern diagnostic and treatment strategies?","volume":"55","author":"Sandler","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0711-1","article-title":"My jamais vu in post allogeneic hematopoietic cell transplant: a review on secondary hemophagocytosis in adults","author":"Alblooshi","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"B8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/bmt.2013.145","article-title":"Etoposide-containing conditioning regimen reduces the occurrence of hemophagocytic lymphohistiocytosis after SCT","volume":"49","author":"Kobayashi","year":"2014","journal-title":"Bone Marrow Transplant."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1002\/art.22656","article-title":"Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial","volume":"56","author":"Brinkman","year":"2007","journal-title":"Arthritis Rheum."},{"key":"B10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fimmu.2019.00055","article-title":"Macrophage activation-like syndrome: a distinct entity leading to early death in sepsis","volume":"10","author":"Karakike","year":"2019","journal-title":"Front Immunol."},{"key":"B11","first-page":"230","article-title":"Reactive macrophage activation syndrome: a simple screening strategy and its potential in early treatment initiation","volume":"132","author":"Emmenegger","year":"2002","journal-title":"Swiss Med Wkly."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1002\/1097-0142(19880515)61:10<2071::AID-CNCR2820611023>3.0.CO;2-6","article-title":"High serum ferritin level as a marker of malignant histiocytosis and virus-associated hemophagocytic syndrome","volume":"61","author":"Esumi","year":"1988","journal-title":"Cancer."},{"key":"B13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ajh.1141","article-title":"Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes","volume":"68","author":"Emmenegger","year":"2001","journal-title":"Am J Hematol."},{"key":"B14","first-page":"299","article-title":"Haemophagocytic syndromes in adults: current concepts and challenges ahead","volume":"135","author":"Emmenegger","year":"2005","journal-title":"Swiss Med Wkly."},{"key":"B15","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/pbc.22774","article-title":"Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality","volume":"56","author":"Lin","year":"2011","journal-title":"Pediatr Blood Cancer."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/pbc.21423","article-title":"Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis","volume":"50","author":"Allen","year":"2008","journal-title":"Pediatr Blood Cancer."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.3324\/haematol.2016.144519","article-title":"Organ siderosis and hemophagocytosis during acute graft-versus-host disease","volume":"101","author":"Nogai","year":"2016","journal-title":"Haematologica."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00277-013-1737-x","article-title":"Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease","volume":"92","author":"Gro\u00dfekatth\u00f6fer","year":"2013","journal-title":"Ann Hematol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"345756","DOI":"10.1155\/2010\/345756","article-title":"Iron overload in patients undergoing hematopoietic stem cell transplantation","volume":"2010","author":"Pullarkat","year":"2010","journal-title":"Adv Hematol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1182\/bloodadvances.2017012310","article-title":"Soluble interleukin-2 receptor is a sensitive diagnostic test in adult HLH","volume":"1","author":"Hayden","year":"2017","journal-title":"Blood Adv"},{"key":"B21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1309\/AJCPMD5TJEFOOVBW","article-title":"Marrow assessment for hemophagocytic lymphohistiocytosis demonstrates poor correlation with disease probability","volume":"141","author":"Ho","year":"2014","journal-title":"Am J Clin Pathol."},{"key":"B22","first-page":"197","article-title":"Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society","volume":"10","author":"Aric\u00f2","year":"1996","journal-title":"Leukemia."},{"key":"B23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s13312-011-0020-2","article-title":"Profile of hemophagocytic lymphohistiocytosis in children in a tertiary care hospital in India","volume":"48","author":"Ramachandran","year":"2011","journal-title":"Indian Pediatr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/annrheumdis-2015-208982","article-title":"Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative","volume":"75","author":"Ravelli","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1365-2141.2009.07863.x","article-title":"High incidence of haemophagocytic syndrome following umbilical cord blood transplantation for adults","volume":"147","author":"Takagi","year":"2009","journal-title":"Br J Haematol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/ajcp\/aqw076","article-title":"Performances of the H-score for diagnosis of hemophagocytic lymphohistiocytosis in adult and pediatric patients","volume":"145","author":"Debaugnies","year":"2016","journal-title":"Am J Clin Pathol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3390\/jcm8040541","article-title":"Prevalence and outcome of secondary hemophagocytic lymphohistiocytosis among SIRS patients: results from a prospective cohort study","volume":"8","author":"Gualdoni","year":"2019","journal-title":"J Clin Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1002\/art.38802","article-title":"Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients","volume":"66","author":"Minoia","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1182\/asheducation-2011.1.178","article-title":"Approach to hemophagocytic syndromes","volume":"2011","author":"Weitzman","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1093\/rheumatology\/ken342","article-title":"Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases","volume":"47","author":"Fukaya","year":"2008","journal-title":"Rheumatology."},{"key":"B33","first-page":"108","article-title":"Dramatic efficacy of cyclosporine A in macrophage activation syndrome","volume":"19","author":"Ravelli","year":"2001","journal-title":"Clin Exp Rheumatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0022-3476(96)70160-9","article-title":"Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases","volume":"129","author":"Mouy","year":"1996","journal-title":"J Pediatr."},{"key":"B35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","article-title":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial","volume":"44","author":"Shakoory","year":"2016","journal-title":"Critical Care Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/art.41103","article-title":"Benefit of anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis","volume":"72","author":"Eloseily","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1002\/art.38092","article-title":"2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications","volume":"65","author":"Ringold","year":"2013","journal-title":"Arthritis Rheumat"},{"key":"B38","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1177\/0885066617711386","article-title":"Interleukin 1 Receptor Antagonist Anakinra, Intravenous Immunoglobulin, and Corticosteroids in the Management of Critically Ill Adult Patients With Hemophagocytic Lymphohistiocytosis","volume":"34","author":"Wohlfarth","year":"2019","journal-title":"J Intensive Care Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1365-2141.1995.tb03302.x","article-title":"Immunomodulation treatment for childhood virus-associated haemophagocytic lymphohistiocytosis","volume":"89","author":"Chen","year":"1995","journal-title":"Br J Haematol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/bjh.12386","article-title":"Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens","volume":"162","author":"Chellapandian","year":"2013","journal-title":"Br J Haematol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3324\/haematol.2015.123562","article-title":"Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies","volume":"100","author":"Lehmberg","year":"2015","journal-title":"Haematologica."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e26308","DOI":"10.1002\/pbc.26308","article-title":"Salvage therapy for refractory hemophagocytic lymphohistiocytosis: a review of the published experience","volume":"64","author":"Marsh","year":"2017","journal-title":"Pediatr Blood Cancer."},{"key":"B43","doi-asserted-by":"publisher","first-page":"S262","DOI":"10.1016\/j.bbmt.2015.11.695","article-title":"Hemophagocytic lymphohistiocytosis (HLH) after hematopoietic stem cell transplant (HSCT) or an Impostor: A Word of Caution!","volume":"22","author":"Vatsayan","year":"2016","journal-title":"Blood Marrow Transplant"},{"key":"B44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrclinonc.2017.148","article-title":"Chimeric antigen receptor T-cell therapy - assessment and management of toxicities","volume":"15","author":"Neelapu","year":"2018","journal-title":"Nat Rev Clin Oncol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1182\/blood.2018894618","article-title":"Recommendations for the management of hemophagocytic lymphohistiocytosis in adults","volume":"133","author":"La","year":"2019","journal-title":"Blood."},{"key":"B46","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.0.CO;2-H","article-title":"HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society","volume":"28","author":"Henter","year":"1997","journal-title":"Med Pediatr Oncol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1600-0609.2012.01757.x","article-title":"Hemophagocytic syndrome after allogeneic hematopoietic cell transplantation: more a graft rejection than an infectious process?","volume":"88","author":"Redjoul","year":"2012","journal-title":"Eur J Haematol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s12291-017-0655-4","article-title":"Hyperferritinemia in hemophagocytic lymphohistiocytosis: a single institution experience in pediatric patients","volume":"33","author":"Basu","year":"2018","journal-title":"Indian J Clin Biochem."},{"key":"B49","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1158\/2159-8290.CD-16-0040","article-title":"Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia","volume":"6","author":"Teachey","year":"2016","journal-title":"Cancer Discov."},{"key":"B50","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0925-5710(97)00584-7","article-title":"Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment","volume":"66","author":"Imashuku","year":"1997","journal-title":"Int J Hematol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.hemonc.2017.07.002","article-title":"Ruxolitinib for secondary hemophagocytic lymphohistiocytosis: First case report","volume":"12","author":"Sin","year":"2019","journal-title":"Hematol Oncol Stem Cell Ther."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2018.07.006","article-title":"Low dose ruxolitinib plus HLH-94 protocol: a potential choice for secondary HLH","author":"Wang","year":"2019","journal-title":"Semin Hematol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1182\/bloodadvances.2017007526","article-title":"Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis","volume":"1","author":"Broglie","year":"2017","journal-title":"Blood Adv."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30156-5","article-title":"Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial","author":"Ahmed","year":"2019","journal-title":"Lancet Haematol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S1470-2045(17)30004-9","article-title":"Malignancy-associated haemophagocytic lymphohistiocytosis in adults","volume":"18","author":"Daver","year":"2017","journal-title":"Lancet Oncol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"828","DOI":"10.4103\/0972-5229.146329","article-title":"Prospective cohort versus retrospective cohort studies to estimate incidence","volume":"18","author":"Kaushal","year":"2014","journal-title":"Indian J Crit Care Med."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00524\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T08:17:12Z","timestamp":1585642632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00524\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,31]]},"references-count":56,"alternative-id":["10.3389\/fimmu.2020.00524"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00524","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,31]]},"article-number":"524"}}